Treatment of CD34+ cells with Nutlin-3, a direct inhibitor of MDM2–p53 interaction (26), leads to p53 accumulation and cell death primarily in the erythroid lineage, providing a mechanistic rationale for the profound anemia in del(5q) MDS (23). This evidence concerns the gene CD34 and myelodysplastic syndrome.